Aspira Women's Health Inc. financial data

Symbol
AWH on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
12117 Bee Caves Road Building Three, Suite 100, Austin, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
VERMILLION, INC. (to 6/10/2020), CIPHERGEN BIOSYSTEMS INC (to 8/17/2007)
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 81.5 % -41.9%
Quick Ratio 4.97 % -2.74%
Debt-to-equity -310 % +77.1%
Return On Equity 516 % -78.9%
Return On Assets -245 % -25.3%
Operating Margin -21.7 % +94.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29.8M shares +141%
Common Stock, Shares, Outstanding 17.4M shares +63.5%
Entity Public Float 21.1M USD +19.3%
Common Stock, Value, Issued 17K USD +54.5%
Weighted Average Number of Shares Outstanding, Basic 14.1M shares +53.1%
Weighted Average Number of Shares Outstanding, Diluted 14.1M shares +53.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 87M USD +963%
Revenue from Contract with Customer, Excluding Assessed Tax 9.18M USD +0.31%
Research and Development Expense 3.27M USD -19.1%
Selling and Marketing Expense 8.15M USD +4.28%
General and Administrative Expense 10.3M USD -15.7%
Operating Income (Loss) -16.3M USD +13.7%
Nonoperating Income (Expense) 3.18M USD +47.3%
Net Income (Loss) Attributable to Parent -13.1M USD +21.5%
Earnings Per Share, Basic -0.93 USD/shares +48.6%
Earnings Per Share, Diluted -0.93 USD/shares +48.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.77M USD -31.9%
Accounts Receivable, after Allowance for Credit Loss, Current 990K USD -32.1%
Inventory, Net 326K USD +43.6%
Other Assets, Current 291K USD
Assets, Current 4.18M USD -20.8%
Property, Plant and Equipment, Net 69K USD -58.2%
Operating Lease, Right-of-Use Asset 1.19M USD +126%
Other Assets, Noncurrent 45K USD +45.2%
Assets 5.49M USD -12.3%
Accounts Payable, Current 2.17M USD +72.3%
Accrued Liabilities, Current 2.45M USD -14.6%
Liabilities, Current 5.47M USD +6.82%
Operating Lease, Liability, Noncurrent 1.25M USD +192%
Liabilities 8.05M USD -6.64%
Retained Earnings (Accumulated Deficit) -531M USD -2.53%
Stockholders' Equity Attributable to Parent -2.56M USD -8.37%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -2.56M USD -8.37%
Liabilities and Equity 5.49M USD -12.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.6M USD +22.3%
Net Cash Provided by (Used in) Financing Activities 5.27M USD
Net Cash Provided by (Used in) Investing Activities -20K USD -150%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 17.4M shares +63.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 818K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.77M USD -38%
Interest Paid, Excluding Capitalized Interest, Operating Activities 6K USD -66.7%
Deferred Tax Assets, Valuation Allowance 60.1M USD +5.05%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 60.3M USD +5.32%
Operating Lease, Liability 1.42M USD +141%
Payments to Acquire Property, Plant, and Equipment 20K USD +150%
Lessee, Operating Lease, Liability, to be Paid 1.77M USD +165%
Property, Plant and Equipment, Gross 1.46M USD -26.1%
Operating Lease, Liability, Current 7K USD -95.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 325K USD +94.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 263K USD +35.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 358K USD +337%
Lessee, Operating Lease, Liability, to be Paid, Year Three 283K USD +65.5%
Deferred Tax Assets, Operating Loss Carryforwards 55.9M USD +6.39%
Unrecognized Tax Benefits 9.26M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 275K USD +227%
Operating Lease, Payments 465K USD +9.16%
Additional Paid in Capital 516M USD +1.44%
Depreciation, Depletion and Amortization 29K USD -58.6%
Deferred Tax Assets, Net of Valuation Allowance 285K USD +132%
Share-based Payment Arrangement, Expense 1.49M USD -13.3%